Description
The purpose of this Notice of Amendment is to announce the revised listing for Adrenocortical hormones to allow the nonprescription use of triamcinolone acetonide for the conditions listed below. Only the Human part of the PDL has been revised.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice - Prescription Drug List (PDL): Triamcinolone acetonide | HTML | Open resource | |
| Notice - Prescription Drug List (PDL): Triamcinolone acetonide | HTML | Open resource |